Main Catalog

Found 88
Sort by
Webinars
Member Free
Non-Member $30.00

2019-2020 Pharmaceutical Marketplace Trends

Not Accredited for CPE: This online program will provide an up-to-the-minute analysis of the pharmaceutical market and offer predictions about what lies ahead in the coming months as the health care industry manages the COVID-19 pandemic.
AMCP eLearning Days 2019-2020 Trends
Nexus Conferences
Member Free
Non-Member $30.00

A Path Forward: Medicaid Accountable Care Organization Implementation

Contact Hours: 1.5. While a dozen states have implemented new Accountable Care Organization (ACO) Medicaid models, another 12 are in the planning phases.
Accountable Care Organization
Nexus Conferences
Member Free
Non-Member $30.00

A State Medicaid’s Experience Implementing an Oversight Program for Behavioral Health Medications in Publicly Insured Youth

Contact Hours: 1.5. Utilization of behavioral health medications in the pediatric population has increased in recent years, a trend that has generated major concern given the limited supporting evidence.
Patient Care
Home Study Programs
Member Free
Non-Member $30.00

AMCP Federal and State Legislative/Regulatory Update Home Study 2020

Contact Hours: 1.0. In today’s world, healthcare legislation and regulation move at a staggering pace making it difficult for health professionals to keep up.
Law
AMCP Annual Meeting
Member Free
Non-Member $30.00

AMCP Headline Session: 2017–2018 Pharmaceutical Marketplace Trends

Not Accredited for CPE: Keeping abreast of industry trends and forecasts is vital to remaining competitive in the evolving managed care arena— especially because market predictions can shape the approach to managing the pharmacy benefit.
AMCP Headline Session 2018
Nexus Conferences
Member Free
Non-Member $30.00

Best Practices in Combating Opioid Abuse, Misuse and Diversion: The Health Plan Perspective - Nexus 2017

Contact Hours: 1.5. The opioid epidemic in the United States continues to worsen. Roughly 91 Americans die each day from an opioid overdose.
Opioid
AMCP Annual Meeting
Member Free
Non-Member $30.00

Best Practices to Implementing Proactive Communications Between Manufacturers and Payers

Contact Hours: 1.25. The recent enactment of the 21st Century Cures Act, and specifically Section 3037 (Cures 3037), modernized provisions of the Food and Drug Administration Modernization Act of 1997, Section 114 (FDAMA 114).
Managed Care Regulation
Nexus Conferences
Member Free
Non-Member $30.00

Biosimilars in the United States: Barriers, Solutions, Real-World Evidence, and the Experience of One Health System

Contact Hours: 1.5. As of July 2019, the U.S. Food and Drug Administration (FDA) had approved 25 biosimilar or follow-on biologic products.
Biosimilars
Nexus Conferences
Member Free
Non-Member $30.00

Bracing for Impact: Preparing for the 2019 Specialty Drug Spend - Nexus 2017

Contact Hours: 1.5. The escalating cost of prescription drugs is an issue that continues to plague the U.S. health care system, accounting for 17% of the total health care spend in 2015.
Hospital/Health Systems
AMCP Annual Meeting
Member Free
Non-Member $30.00

Brand and Generic Drugs in Development

Contact Hours: 1.25. This session focuses on new and emerging brand-name drugs, as well as upcoming generic drug approvals.
Brand and Generic Drugs
Nexus Conferences
Member Free
Non-Member $30.00

Budget Impact Models: How Payers Can Build and Validate - Nexus 2017

Contact Hours: 1.5. Budget impact models (BIMs) can be built and used by payers for many decisions, including changes to the formulary.
Hospital/Health Systems
Webinars
Member Free
Non-Member $30.00

Cannabis Use in Health Care: What Payers Need to Know Home Study

Contact Hours: 1. 0 - Despite a lack of regulatory and legal clarity, significant numbers of patients in Medicare, Medicaid, CHIP, and commercial plans currently use medical cannabis.
AMCP eLearning Days Cannabis
Nexus Conferences
Member $15.00
Non-Member $30.00

Checking In on Health Care Reform Efforts: What Do They Mean for Payers, Manufacturers and Patients?

Contact Hours: 1.5. While broader drug pricing reform efforts have taken the lion’s share of attention in health policy discourse over the past year, the Trump Administration has continued to move forward with implementing changes to the Affordable Care Act (ACA).
Health Care Reform
Nexus Conferences
Member Free
Non-Member $30.00

Collaborative Multiple Sclerosis Care Management Approach

Contact Hours: 1.5. Multiple sclerosis is a debilitating, chronic illness and a key driver of medical and pharmacy costs.
Multiple Sclerosis
Nexus Conferences
Member Free
Non-Member $30.00

Coverage and Reimbursement for High Cost Curative Therapeutics: Does a Solution Exist? - Nexus 2018

Contact Hours: 1.5. More and more, managed care organizations are straddling the line between making new, innovative therapies available to their patients and ensuring they can cover the costs of these therapies.
Drug Pricing
Webinars
Member Free
Non-Member $30.00

Developing Professional Strategies to Enhance Digital Engagement

Not Accredited for CPE: 2020 will no doubt be the year of digital engagement. On this webinar, Digital Marketing Strategist Eddie Bradley will share tips and insights on how subject matter experts and industry leading brands are leveraging content to grow and further engage with their audience.
Digital Engagement AMCP eLearning Days
AMCP Annual Meeting
Member $15.00
Non-Member $30.00

Developments, Research, Pipeline, and Applications of Gene Therapy - Annual 2019

Contact Hours: 0.75: Gene therapy is a promising treatment option for a number of diseases, including inherited disorders, some types of cancer, and certain viral infections. The first gene therapy approvals in the United States occurred in 2017.
Gene Therapy
Home Study Programs
Member Free
Non-Member $30.00

Diabetes: Value Based Insurance Designs (VBID) Real World Evidence

Contact Hours: 1.5. Self-insured employers frequently consider implementing a diabetes value-based insurance design (VBID) as a cost-effective solution for their employees.
Diabetes
Webinars
Member Free
Non-Member $30.00

Digital Therapeutics: Understanding the Emerging Product Class Home Study

Contact Hours: 1.0. Digital therapeutics (DTx) are emerging as a novel treatment modality for a wide range of health conditions, either as stand-alone products or for use in conjunction with other treatments.
Digital Health AMCP eLearning Days
Webinars
Member Free
Non-Member $30.00

Drug Pipeline: Traditional Pharmaceuticals and Biosimilars Home Study

Contact Hours: 1.0. This session focuses on new and emerging traditional pharmaceutical brand-name drugs, as well as upcoming generic and biosimilar drug approvals.
Drug Pipeline AMCP eLearning Days
Nexus Conferences
Member Free
Non-Member $30.00

End of an Era: Lessons Learned from 2018 CMS Audits, and Prep for the Future - Nexus 2018

Contact Hours: 1.5. Ready for that upcoming 2019 audit? Do you know how to prepare? If your answer is no, join this session to hear how health plans prepare for their audits and address corrective actions, as lessons learned from the 2018 audit season are discussed.
CMS
Webinars
Member Free
Non-Member $30.00

Evaluating Digital Therapeutics, Drugs, and Health Technology for Optimizing Clinical and Financial Outcomes Home Study

Contact Hours: 1.0. Utilization management practices are applied to medications in many therapeutic areas, but present unique challenges with digital therapeutics (DTx) and digital health tools.
Digital Health AMCP eLearning Days
Nexus Conferences
Member Free
Non-Member Free

Expanding the Managed Care Professional’s Digital Therapeutics IQ - Home Study

Contact Hours: 1.5. Digital therapeutics are expanding the boundaries of the types of therapies that health care decision-makers must be adept at evaluating.
Digital Health
Nexus Conferences
Member Free
Non-Member $30.00

Experience and Lessons Learned in Biosimilar Uptake - Nexus 2018

Contact Hours: 1.5. Although biosimilars have been on the market for some time, payers continue to face many challenges in implementation.
Biosimilars
Nexus Conferences
Member $15.00
Non-Member $30.00

Fast and Furious: What is Driving the Specialty Spend?

Contact Hours: 1.5. In 2018, the United States spent an estimated $517 million on specialty drugs. While specialty medications make up only about 1–2 % of all prescriptions written, they account for nearly 50% of total drug spend.
Specialty Drug Spend
AMCP Annual Meeting
Member Free
Non-Member $30.00

Federal and State Legislative and Regulatory Update - Annual Meeting 2018

Contact Hours: 1.25. This must-attend session will bring you timely updates on the latest federal and state legislative and regulatory actions of interest to pharmacists and other managed care and specialty pharmacy professionals.
Law
AMCP Annual Meeting
Member Free
Non-Member $30.00

Federal and State Legislative and Regulatory Update - Annual Meeting 2019

Contact Hours: 1.25. This must-attend session will bring you timely updates on the latest federal and state legislative and regulatory actions of interest to managed care and specialty pharmacy professionals.
Law
Nexus Conferences
Member Free
Non-Member $30.00

Federal and State Legislative and Regulatory Update - Nexus 2017

Contact Hours: 1.5. This must-attend session will bring you timely updates on the latest federal and state legislative and regulatory actions of interest to managed care and specialty pharmacy professionals.
Law
Nexus Conferences
Member Free
Non-Member $30.00

Federal and State Legislative and Regulatory Update - Nexus 2018

Contact Hours: 1.5. This must-attend session will bring you timely updates on the latest federal and state legislative and regulatory actions of interest to managed care and specialty pharmacy professionals.
Law
AMCP Annual Meeting
Member $15.00
Non-Member $30.00

Financial Models to Manage Drug Spend of Gene Therapy - Annual Meeting 2019

Contact Hours 1.0: Gene therapy techniques offer potential breakthroughs for patients with serious health conditions. They also are associated with significant short-term costs yet hold the promise of long-term savings.
Gene Therapy
Certificate Programs
Member $399.00
Non-Member $499.00

Fundamentals of Managed Care Pharmacy Certificate Program 2nd Edition - Professional Version

Contact Hours: 8.75 (0.875 CEUs). The Fundamentals of Managed Care Pharmacy Certificate Program provides a comprehensive introduction to basic concepts in managed care pharmacy.
Fundamentals of Managed Care Pharmacy
Certificate Programs
Member $199.00
Non-Member $249.00

Fundamentals of Managed Care Pharmacy Certificate Program 2nd Edition | Student Version

The Fundamentals of Managed Care Pharmacy Certificate Program provides a comprehensive introduction to basic concepts in managed care pharmacy.
Fundamentals of Managed Care Pharmacy
AMCP Annual Meeting
Member $15.00
Non-Member $30.00

Gene Therapy for Hemophilia: Hope for a Cure? - Annual Meeting 2018

Contact Hours: 0.75. The best currently available treatments for hemophilia reduce but do not eliminate the possibility of bleeding.
Hemophilia
Webinars
Member Free
Non-Member $30.00

Getting Up to Speed on Prescription Drug Pricing Reform Efforts Home Study

Contact Hours: 1.0. Prescription drug pricing reform is a high-profile issue heading into the 2020 elections. President Trump, members of Congress, and the Democratic presidential candidates.
AMCP eLearning Days Drug Pricing
Online Course
Member Free
Non-Member $69.00

Health Care Trends and the Impact of COVID19

Not Accredited for CPE: Take a fresh look at marketplace trends since the COVID-19 pandemic began. Webinar Description Webpage Content:
COVID19
Webinars
Member Free
Non-Member $30.00

Health Policy Trends Impacting Managed Care Pharmacy: Are You Ready?

Not Accredited for CPE: Congress, the White House, and presidential candidates are proposing major health policy changes in an election year where health care is a top issue on voters’ minds.
Health Policy AMCP eLearning Days
Nexus Conferences
Member $15.00
Non-Member $30.00

How Continued Drug Shortages Compromise Patient Care

Contact Hours: 1.5. Providing safe and effective drug therapy has become extremely challenging during extended periods of drug shortages.
Drug Shortages
Nexus Conferences
Member Free
Non-Member $30.00

Improving Star Ratings Through Focused Clinical Strategy and Targeted Outreach: Results from a Systematic Approach - Nexus 2018

Contact Hours: 1.5. Star Ratings continue to evolve as measure specifications, benchmarks and inclusion into the overall calculation continue to change under Medicare.
CMS
Home Study Programs
Member Free
Non-Member $30.00

Incorporating Best Practices in Transgender Health Policies and Formulary Development into Your Health Plan

CPE 1.5 | 1.5 AMA PRA | Nurse 1.5 Contact Hours | The Centers for Disease Control and Prevention (CDC) estimates that an increasing number of Americans—currently, 1.4 million adults—identify as transgender.
Hospital/Health Systems
Nexus Conferences
Member $15.00
Non-Member $30.00

Increasing Positive Outcomes: The Impact of Social Determinants of Health

Contact Hours: 1.5. There is a growing body of evidence that highlights how social determinants of health—socioeconomic status, education, physical environment, employment, and social support networks—play a large role in determining overall health outcomes.
Social Determinants
Nexus Conferences
Member $15.00
Non-Member $30.00

Innovative Value-Based Contracting Approaches with Comprehensive Clinical Strategies

Contact Hours: 1.5. Innovative approaches to developing value-based contracts in the market need to be multi-faceted.
Value-Based Contracting
AMCP Annual Meeting
Member $15.00
Non-Member $30.00

Introduction to Gene Therapy: Key Terms, Concepts, and International Perspectives - Annual Meeting 2019

Contact Hours: 1.0 : Gene therapy is an investigational technique that offers exciting promise of curing many debilitating and potentially terminal diseases, such as cystic fibrosis, multiple sclerosis, hemophilia, sickle cell disease, and spinal muscular atrophy.
Gene Therapy
AMCP Annual Meeting
Member Free
Non-Member $30.00

It’s an ART: Formulary and Drug Use Management Strategies for HIV Medications - Annual 2019

Contact Hours: 1.25. As people with HIV age, the focus of disease management places more emphasis on the safety of long-term medication use and managing comorbidities. The advantages of safer, more efficacious medications also come with increased cost.
HIV
AMCP Annual Meeting
Member Free
Non-Member $30.00

Key Forces Driving Change in Oncology

Contact Hours: 1.25. Oncology practice is changing rapidly as new advances in innovation lead to new evidence and testing requirements, as well as treatment guidelines.
Oncology
AMCP Annual Meeting
Member $15.00
Non-Member $30.00

Managing Patients with Hemophilia: A Payer’s Perspective - Annual Meeting 2018

Contact Hours: 1.0. Thanks to significant improvements in the treatment of hemophilia, patients are living longer than ever before, with higher expectations for
near-normal quality of life.
Hemophilia
AMCP Annual Meeting
Member Free
Non-Member $30.00

Measuring Value of an IDN Specialty Pharmacy Therapy Management Program for Biologics

Contact Hours: 1.25: Gene therapy is a promising treatment option for a number of diseases, including inherited disorders, some types of cancer, and certain viral infections. The first gene therapy approvals in the United States occurred in 2017.
Specialty
Nexus Conferences
Member Free
Non-Member $30.00

Medical Benefit Medication Management - Low Hanging Fruit to Complex Strategy - Nexus 2017

Contact Hours: 1.5. Are you up to speed on the latest industry best practices in managing your medical-benefit medications?
Hospital/Health Systems
Nexus Conferences
Member Free
Non-Member $30.00

Medical Oncology Drug Cost Trends and Innovative, Practical Payer Management Strategies - Nexus 2018

Contact Hours: 1.5. Medical oncology drugs represent 35 to 47% percent of total medical benefit drug spend.
Oncology
AMCP Annual Meeting
Member Free
Non-Member $30.00

Medicare Formulary Updates Impact

Contact Hours: 1.25. The Centers for Medicare and Medicaid (CMS) continues to critically evaluate formulary regulations and guidance to help lower drug costs.
Medicare
AMCP Annual Meeting
Member Free
Non-Member $30.00

More than Meets the Eye–Value-Based Contracts are More Prevalent than We Think

Contact Hours: 1.25. As the U.S. health care system evolves from a volume-driven system to one that rewards value, there is growing interest in value-based payment arrangements.
Value-Based Contracting